A Curious Case of Vanishing Hepatocellular Carcinoma (HCC)

被引：0
|
作者：
Kwei-Nsoro, Robert [1 ]
Attar, Bashar [2 ,3 ]
Ojemolon, Pius E. [1 ]
Annor, Eugene N. [4 ]
Go, Benjamin [5 ]
机构：
[1] John H Stroger Jr Hosp Cook Cty, Internal Med, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Gastroenterol & Hepatol, Chicago, IL USA
[3] John H Stroger Jr Hosp Cook Cty, Gastroenterol & Hepatol, Chicago, IL USA
[4] Univ Illinois, Internal Med, Chicago, IL USA
[5] John H Stroger Jr Hosp Cook Cty, Gastroenterol, Chicago, IL USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 10期
关键词：
systemic inflammatory response; tumor hypoxia; alcohol related cirrhosis; spontaneous tumor regression; hepatocellular carcinoma (hcc); SPONTANEOUS REGRESSION; SPONTANEOUS NECROSIS;
D O I：
10.7759/cureus.46576
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality worldwide. Spontaneous regression of HCC is rare with few documented cases in literature. The mechanism of this phenomenon is unknown, but tumor hypoxia and systemic inflammatory response have been suggested as possible etiologies. This article aims to shed more light on this rare phenomenon and provides an opportunity to review the proposed pathophysiology of spontaneous HCC regression. In this case report, we describe an interesting case of a 39-year-old male with HCC who underwent spontaneous regression.
引用
收藏
页数：7
相关论文
共 50 条
  • [41] Prevention of Hepatocellular Carcinoma (HCC) with antiviral therapy
    Di Bisceglie, Adrian M.
    CANCER RESEARCH, 2017, 77 (22)
  • [42] Association between Helicobacter and hepatocellular carcinoma (HCC).
    De Man, RA
    Pot, R
    Verhoef, C
    Zondervan, P
    Van der Breggen, R
    Ijzermans, R
    Kuipers, EJ
    Kusters, HG
    HEPATOLOGY, 2001, 34 (04) : 669A - 669A
  • [43] Autoimmune Hepatitis, Cirrhosis, and Hepatocellular Carcinoma (HCC)
    Trivedi, Palak Jitendrakumar
    Cullen, Sue
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (02) : 276 - 278
  • [44] ADRIAMYCIN IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA (HCC)
    GENNARI, L
    TOMMASINI, MA
    OREFICE, S
    BIGNAMI, AM
    MAGGI, CA
    COLUCCI, G
    COLOMBO, M
    GASTROENTEROLOGY, 1981, 80 (05) : 1333 - 1333
  • [45] LUPOID HEPATITIS AND HEPATOCELLULAR-CARCINOMA (HCC)
    LIEW, CT
    KANEL, GC
    HEPATOLOGY, 1985, 5 (05) : 1051 - 1051
  • [46] Autoimmune Hepatitis, Cirrhosis, and Hepatocellular Carcinoma (HCC)
    Palak Jitendrakumar Trivedi
    Sue Cullen
    Digestive Diseases and Sciences, 2011, 56 : 276 - 278
  • [47] Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview
    Rashed, Wafaa M.
    Kandeil, Mohamed Ahmed Mohamed
    Mahmoud, Mohamed O.
    Ezzat, Sameera
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2020, 32 (01)
  • [48] A novel combinatorial therapy for hepatocellular carcinoma (HCC)
    Srivastava, Jyoti
    Rajasekaran, Devaraja
    Siddiq, Ayesha
    Gredler, Rachel
    Robertson, Chadia L.
    Akiel, Maaged A.
    Shen, Xue-Ning
    Ebeid, Kareem A. N.
    Salem, Aliasger K.
    Fisher, Paul B.
    Sarkar, Devanand
    CANCER RESEARCH, 2015, 75
  • [49] Chemotherapy and medical treatment of hepatocellular carcinoma (HCC)
    Rougier, P
    Mitry, E
    Clavero-Fabri, MC
    HEPATO-GASTROENTEROLOGY, 1998, 45 : 1264 - 1266
  • [50] PREVALENCE OF AUTOIMMUNE DISORDERS IN HEPATOCELLULAR CARCINOMA (HCC)
    Kavati, Abhishek
    Farej, Ryan
    Babajanyan, Svetlana
    Hopson, Sari
    HEPATOLOGY, 2020, 72 : 648A - 649A
12345